Kidney Cancer Trial, Recruiting NCT06751498 Sponsor: Shao Pengfei Condition: Kidney Cancer
Back to Kidney Cancer

Kidney Cancer Trial, Recruiting

NCT06751498
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with an early-stage (stage cT1) kidney tumor that has been confirmed by a CT scan or MRI before surgery
  • You are scheduled to have a surgery called a partial nephrectomy (where only part of the kidney is removed, not the whole kidney)
  • Your kidney tumor has not spread to the lymph nodes or other parts of the body
  • You are generally in good physical health and able to carry out normal daily activities (confirm with trial site)
  • Your doctor expects you to live for more than 10 years

Who may not be able to join:

  • Your tumor cannot be safely removed through surgery
  • Your kidneys are not working well enough before surgery, based on a specific blood test result (confirm with trial site for exact threshold)
  • You have already received targeted therapy, immunotherapy, or chemotherapy before surgery
  • You have any medical condition that makes surgery unsafe for you (confirm with trial site)
  • During surgery, it turns out the whole kidney needs to be removed instead of just part of it
  • You receive targeted therapy, immunotherapy, or chemotherapy at any point during your follow-up care after surgery
  • You have a serious ongoing illness affecting your overall health

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shao Pengfei
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
1 April 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

GFR of ipsilateral and contralateral kidneys; volume of ipsilateral kidney

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov